
Surgeon General Makes Opioid-Related Recommendation
The U.S. Surgeon General issued an advisory recommending more Americans carry the opioid reversing drug naloxone.
Welcome to Practice Rounds, our weekly column exploring what's being covered in the larger world of health care.
Surgeon General Makes Opioid-related Recommendation
The U.S. Surgeon General this week issued an advisory recommending that more Americans carry an opioid reversing drug, naloxone. The drug, sold under the brand name Narcan, can restore normal breathing if someone has overdosed on opioids. Jerome Adams, MD, says knowing how to use naloxone and having it available can save someone's life. "Despite evidence of the effectiveness of naloxone in reducing opioid overdose deaths, awareness of the drug’s benefits and its possession and use among patients, prescribers, community bystanders, and even first responders in some areas remains limited," Adams wrote in
JP Morgan CEO Talks Health Venture
Few details have emerged regarding the
HHS, ONC Release New Resource
The Department of Health and Human Services (HHS) and its Office of the National Coordinator for Health IT (ONC) jointly released a new resource for individuals, patients, and caregivers to more easily access their health information. HHS says the resource supports a goal in the 21st Century Cures Act empowering patients and improving patients’ access to their EHR via the
Quote of the Week:
"Since patients cannot purchase drugs without a prescription, nor do they have the depth of knowledge to understand the process of drug selection, I wish there were no direct to consumer ads for drugs."
Melissa Young, MD, Endocrinologist, Freehold, N.J.
Newsletter
Optimize your practice with the Physicians Practice newsletter, offering management pearls, leadership tips, and business strategies tailored for practice administrators and physicians of any specialty.











